1. Introduction
===============

Postoperative atrial fibrillation (AF) is a common postoperative arrhythmia in patients who have undergone all types of cardiac operations, including those with coronary artery bypass grafting (CABG).^\[[@R1]\]^ Its incidence has been reported to be as high as 45% to 65%.^\[[@R2],[@R3]\]^ AF most often occurs from the second to the fourth postoperative day.^\[[@R4]\]^ Although most cases are self-limiting, postoperative AF may cause serious complications, increased cost, and prolonged hospital stay.^\[[@R5]\]^ The development of AF after CABG surgery increases the morbidity and mortality, length of hospital stay, and hospital costs.^\[[@R6],[@R7]\]^ Reduction in its occurrence may result in enormous savings; thus, interests in the identification of risk factors that may enable implementation of preventative strategies are increasing.

The pathophysiology of new-onset postoperative AF remains unclear. Recent evidence supports an inflammatory mechanism in the development of AF.^\[[@R8]--[@R10]\]^ Transfused red blood cell (RBC) or whole blood transfusions (BT) modulate the inflammatory response to cardiac surgery by changing many inflammatory mediators and augmenting the inflammatory response.^\[[@R11]--[@R13]\]^ In addition, the inflammation level is related to the preoperative status and triggers associated with cardiac surgery.

Previous studies assessed the association of RBC transfusion and the risk of postoperative AF after cardiac surgery.^\[[@R8],[@R14]--[@R20]\]^ However, these studies have a modest sample size and convey inconclusive results. To obtain a more comprehensive estimate of the association between BT and the risk of postoperative AF after cardiac surgery, we conducted a meta-analysis to systematically evaluate the association between BT and the risk of postoperative AF in adult patients who had undergone CABG surgery.

2. Methods
==========

The present meta-analysis was conducted in accordance with the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines.^\[[@R21]\]^ All analyses were based on previous published studies; thus, no ethical approval and patient consent were required.

2.1. Search strategy
--------------------

We conducted an electronic search on PubMed, Embase, and Cochrane Library databases from their dates of inception to January 2017 for cohort studies published in English. The search terms "blood transfusion or red blood cell" and "postoperative atrial fibrillation or atrial fibrillation" were combined with "coronary artery bypass or coronary bypass or myocardial revascularization or aortic valve or mitral valve or ascending aorta or cardiac surgery" as both keywords and exploded medical subject headings. We restricted the search to human studies. In addition, we reviewed the reference lists of the obtained articles to identify additional relevant studies. If multiple published reports from the same study were available, we included only one of them that contained the most detailed information for both exposure and outcome.

2.2. Eligibility criteria
-------------------------

Studies that met the following criteria were included: cohort study with adult patients (i.e., 18 years or older) who underwent CABG surgery; reported outcomes of postoperative new-onset AF at least; the exposure of interest was BT or RBC; and reported adjusted risk estimates for the association between BT and/or RBC, and postoperative AF, or had reported data with which to calculate these. Studies were excluded if they met the following exclusion criteria: reported a cross-sectional, case-control, randomized controlled trial; reported only unadjusted or only age- and sex-adjusted odds ratios (OR); did not report 95% confidence intervals (CIs); the exposure of interest was not BT or RBC; and the outcome was not postoperative new-onset AF.

2.3. Data extraction
--------------------

Data were extracted independently by 2 investigators and reviewed by a third investigator. The following data were extracted: first author\'s surname, year of publication, country, type of surgery, number of participants, number of AF cases, aortic cross-clamping time, and cardiopulmonary bypass (CPB) time, study period, type of blood products, and study design. A predesigned Excel (Microsoft Corporation) file was used to extract relevant information.

2.4. Quality assessment
-----------------------

The quality assessment of each study was conducted independently by 2 authors in accordance with the Newcastle--Ottawa scale for nonrandomized studies.^\[[@R22]\]^ The NOS contains 3 categories (selection, comparability, and outcome) and eight items. In the selection and outcome categories, a quality research item received one star, and a comparable category could receive at most 2 stars. In the selection part, studies that precisely described the item (i.e., those drawn from the same community as the exposed cohort with secure records and a demonstration that outcome of interest was not present at start of the study) received one star. Regarding comparability, 2 items (i.e., study controls as the most important factor, and study controls as an additional factor) could receive a star if the study was eligible. In the outcome portion, various items (i.e*.,* outcome assessments, a follow-up that was sufficiently long for outcomes to occur, and adequate follow up of cohorts) could elicit one star each if the study presented the corresponding details. The full score was 9 stars. We assigned scores of 0--3, 4--6, and 7--9 for low-, moderate-, and high-quality studies, respectively.^\[[@R23],[@R24]\]^

2.5. Statistical analysis
-------------------------

The level of statistical significance for the two-tailed test of each hypothesis was 0.05. All statistical analyses were conducted using the Review Manager version 5.3 (The Cochrane Collaboration, Software Update, Oxford, UK) and Stata version 11.0 (Stata Corporation, College Station, TX). The measure of interest was the OR (odds ratio). When available, adjusted ratios were extracted. We combined these estimates by using a random-effects model, which takes into account both within- and between-study variabilities.^\[[@R25]\]^ A *P* value of \<.10 was used to indicate the lack of homogeneity (heterogeneity) among the effects. We also calculated the *I*^2^ statistics, a quantitative measure of inconsistency across studies.^\[[@R26]\]^ If evidence of heterogeneity was found, stratified syntheses and sensitivity analyses were performed to explain what contributed to the heterogeneity. We performed predefined stratified analyses in accordance with the study design (prospective cohort vs retrospective cohort), surgery type (CABG vs CABG ± valve replacement), and country (USA vs non-USA). We calculated linear *P* for trend and *P* for interaction for stratified analyses. Potential publication bias was assessed based on Begg\'s test and the symmetry of the funnel plot.^\[[@R26]--[@R28]\]^

3. Results
==========

3.1. Literature search
----------------------

In the electronic database searches, 991 unique records were identified. Of these records, 977 were excluded on the basis of the title and abstract content. Fourteen articles were subjected to full-length article review. Based on the abstract and full text, 6 of the records were excluded for clearly not fulfilling the inclusion criteria, which included article type, original data, population, or outcome of interest. Finally, 8 cohort studies (4 retrospective cohort studies and 4 prospective cohort studies) involving 7401 AF cases and 31,069 participants met the criteria for inclusion^\[[@R8],[@R14]--[@R20]\]^ (Fig. [1](#F1){ref-type="fig"}). The eligible studies were published between 2006 and 2016. The study characteristics and quality assessment scores are summarized in Table [1](#T1){ref-type="table"} and Supplementary Table 1.
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Study characteristics.
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3.2. Blood transfusion and postoperative atrial fibrillation risk
-----------------------------------------------------------------

Pooling the results of individual studies, blood product transfusion in adult patients who underwent CABG surgery was associated with an increased risk of developing postoperative AF (OR, 1.45; 95% CI, 1.26--1.67; Fig. [2](#F2){ref-type="fig"}). Evidence of significant heterogeneity in the magnitude of the association across studies was found (*P* for heterogeneity \< .0001, *I*^2^ = 79%). No evidence was detected for publication bias by inspection of the funnel plot and formal statistical tests (Begg\'s test, *P* = .174; Supplementary Fig. 1).

![Forest plot showing the pooled odds ratio for postoperative AF after CABG. AF = atrial fibrillation, CABG = coronary artery bypass grafting, BT = blood transfusion.](medi-97-e9700-g003){#F2}

3.3. Stratified analysis
------------------------

The results of the stratified analyses are presented in Table [2](#T2){ref-type="table"}. After stratification by surgery type, the associations between BT and risk of postoperative AF were established to be similar between the adult patients who underwent CABG surgery (OR, 1.59; 95% CI, 1.17--2.14; n = 5) and CABG ± VR (OR, 1.40; 95% CI, 1.17--1.69; n = 3). The pooled OR of AF were 1.34 (95% CI, 1.18--1.51; n = 4) for studies conducted in the United States and 1.82 (95% CI, 1.15--2.89; n = 4) for studies conducted in the non-United States countries. After stratification by study design, BT was associated with an increased risk of postoperative AF in both subgroups (prospective and retrospective cohorts).
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Stratified analyses of blood transfusion and atrial fibrillation risk.
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3.4. Sensitivity analysis
-------------------------

The robustness of our results was evaluated by using sensitivity analysis. When studies included in the meta-analysis were deleted one at a time, the results remained largely unchanged, indicating that these results were stable (data not shown). Exclusion of studies that included off-pump CABG yielded a pooled OR of 1.36 (95% CI, 1.23--1.50; n = 7). Restricting analysis to studies that reported blood products yielded a pooled OR of 1.39 (95% CI, 1.21--1.61; n = 7), with substantial heterogeneity (*P* = .0003; *I*^2^ = 76%). Further analyses that examined the influence of a single study on the results by omitting a study at each turn yielded an OR ranging from 1.36 to 1.53.

4. Discussion
=============

In this present meta-analysis, we reviewed eight cohort studies regarding the association between BT and risk of postoperative AF in adult patients who had undergone a CABG surgery. The pooled results using a random-effects model demonstrated a significant association between BT and postoperative AF with an overall 1.45-fold (95% CI, 1.26--1.67) increased risk in comparison with that in the non-BT participants. The increased risk was consistently observed across the studies but did not reach statistical significance in one study.^\[[@R20]\]^

4.1. Results in relation to other studies
-----------------------------------------

To date, the relationship between BT and the risk of postoperative AF in adult patients who had undergone CABG surgery is controversial, and the results of the observational studies have been inconsistent. Similar to our findings, several studies have demonstrated an increased risk of postoperative AF in patients with BT.^\[[@R8],[@R14]--[@R20]\]^ In particular, a retrospective cohort study showed that BT was associated with the incidence of AF after CABG surgery (adjusted OR, 1.36; 95% CI, 1.11--1.68).^\[[@R19]\]^ It is noteworthy that this risk increases with the increase in the number of BTs. Nevertheless, another study that investigated BT failed to demonstrate an association with postoperative AF.^\[[@R20]\]^ Moreover, patients from this observational study did not receive transfusion regardless of hematocrit level and were probably predisposed to danger that would have been preventable. Hematocrit level has been shown to be a strong predictor of adverse outcomes in CABG surgery.^\[[@R29]\]^ This may partly explain the inconsistency of the earlier findings. In addition, the authors also reported that this possible association was a result of the poor health status of the patients in the preoperative period and suggested the importance of a careful preoperative evaluation because it can reduce the risk of bleeding and the need for blood transfusion during the postoperative period.^\[[@R17]\]^

4.2. Potential mechanism
------------------------

The increased risk of postoperative AF events in patients with BT is not well understood. A previous work that used animal models showed that when activated, neutrophils bind to cardiac myocytes, thereby causing changes in myocyte electrical activity that could be arrhythmogenic.^\[[@R30]\]^ CPB can lead to the production of different proinflammatory mediators alongside widespread endothelial activation with increased expression of adhesion molecules and impaired release of nitric oxide. RBCs can be stored for up to 42 days before transfusion. Many biochemical and morphological alterations are progressively occurring during RBCs storage, such as impairment of nitric-oxide-mediated functions, depletion of adenosine triphosphate and 2,3-diphosphoglycerate, and increased lipid peroxidation. Moreover, the heart is exposed to proinflammatory cytokines invoked by heart ischemia or trauma, which triggers the release of oxygen radicals and depletion of plasma antioxidants. As a result, the inflammatory reaction leads to electrophysiological alterations in atrial myocytes. The increased levels of interleukin 6 (IL-6), tumor necrosis factor α (TNF-α), and C-reactive protein (CRP) have all been associated with postoperative AF.^\[[@R31]--[@R33]\]^ Transforming growth factor beta 1 (TGF-β1) has also been implicated in the pathology of AF in animal models. The analysis of human right atrial tissue has demonstrated the presence of higher levels of total and active TGF-β1 in patients who developed postoperative AF than in patients who remained in sinus rhythm.^\[[@R34]\]^ The impact of TGF-β1 on the development of postoperative AF may be related to the possibility that the factor can promote the expression of fibrosis-related genes in a Smad2-related pathway.^\[[@R35]\]^ Furthermore, the renin-angiotensin-aldosterone (RAA) system may have a key role in the development of AF.^\[[@R36],[@R37]\]^ On the other hand, many preoperative and intraoperative factors, such as increased age, diabetes mellitus, kidney disease, central nervous system and lung diseases, atrial cannulation, CPB, type of cardioplegia, impaired left ventricular function, and peripheral vascular disease, have been associated with postoperative AF.^\[[@R38],[@R39]\]^

4.3. Clinical implications
--------------------------

Nonetheless, we do not hesitate to suggest that aggressive attempts at BT are warranted. The measurements of serum iron and the preoperative administration of iron and preoperative erythropoietin may reduce the need for hemoderivatives.^\[[@R40]\]^ Koch et al^\[[@R8]\]^ demonstrated that the transfusions of fresh frozen plasma and platelets exerts the same effects in patients with CAGS. Based on our findings, we can conclude that if a patient requires a blood transfusion during or post-CAGS, the comprehensive strategy for BT should be evaluated regarding the development of other postoperative complications but not the new onset of postoperative AF.

Even though 8 included studies were of high quality, some limitations remained. Thus, the results of this research should be interpreted with caution. First, in all of the included studies, the patients received RBC transfusion, but the storage time of the transfused RBCs, and the volume and rate of transfusion were not considered. Second, this is a meta-analysis of observational studies that, at the best, can demonstrate an association but cannot establish cause and effect. Therefore, we cannot be certain that BT itself in comparison with other potential confounding factors (e.g., hemoderivatives, oxygen concentration, and temperature) was the cause of the increased postoperative AF risk. Furthermore, these studies were at risk of detection bias, as the patients in their cohorts, because of their myopathy, were exposed to more medical examinations and investigations, and thus to a higher likelihood of AF prevention. Finally, another possible limitation is due to language bias. We attempted to minimize this bias by searching 3 major electronic databases with no language restriction. However, some articles published in Chinese or other non-English languages might not have appeared in international journal databases and could have been missed by our searches.

5. Conclusion
=============

The findings of the present meta-analysis demonstrate a statistically significant higher postoperative AF risk among adult patients with BT. Further prospective large-scale studies are needed to establish causality and to elucidate the underlying mechanisms.
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Appendix: PubMed search terms
=============================

\#1: Search "Coronary Artery Bypass"\[Mesh\] Sort by: Relevance

\#2: Search (((((((((((Artery Bypass, Coronary\[Title/Abstract\]) OR Artery Bypasses, Coronary\[Title/Abstract\]) OR Bypasses, Coronary Artery\[Title/Abstract\]) OR Coronary Artery Bypasses\[Title/Abstract\]) OR Coronary Artery Bypass Surgery\[Title/Abstract\]) OR Bypass, Coronary Artery\[Title/Abstract\]) OR Aortocoronary Bypasses\[Title/Abstract\]) OR Aortocoronary Bypass\[Title/Abstract\]) OR Bypass, Aortocoronary\[Title/Abstract\]) OR Bypasses, Aortocoronary\[Title/Abstract\]) OR Bypass Surgery, Coronary Artery\[Title/Abstract\]) OR Coronary Artery Bypass Grafting\[Title/Abstract\] Sort by: Relevance

\#3: \#1 OR \#2

\#4: Search "Atrial Fibrillation"\[Mesh\] Sort by: Relevance

\#5: Search ((((((((((((((((((((((((Fibrillation, Atrial\[Title/Abstract\]) OR Fibrillations, Atrial\[Title/Abstract\]) OR Auricular Fibrillation\[Title/Abstract\]) OR Atrial Fibrillations\[Title/Abstract\]) OR Auricular Fibrillations\[Title/Abstract\]) OR Fibrillation, Auricular\[Title/Abstract\]) OR Fibrillations, Auricular\[Title/Abstract\]) OR Persistent Atrial Fibrillation\[Title/Abstract\]) OR Atrial Fibrillation, Persistent\[Title/Abstract\]) OR Atrial Fibrillations, Persistent\[Title/Abstract\]) OR Fibrillation, Persistent Atrial\[Title/Abstract\]) OR Fibrillations, Persistent Atrial\[Title/Abstract\]) OR Persistent Atrial Fibrillations\[Title/Abstract\]) OR Familial Atrial Fibrillation\[Title/Abstract\]) OR Atrial Fibrillation, Familial\[Title/Abstract\]) OR Atrial Fibrillations, Familial\[Title/Abstract\]) OR Familial Atrial Fibrillations\[Title/Abstract\]) OR Fibrillation, Familial Atrial\[Title/Abstract\]) OR Fibrillations, Familial Atrial\[Title/Abstract\]) OR Paroxysmal Atrial Fibrillation\[Title/Abstract\]) OR Atrial Fibrillation, Paroxysmal\[Title/Abstract\]) OR Paroxysmal Atrial Fibrillations\[Title/Abstract\]) OR Fibrillations, Paroxysmal Atrial\[Title/Abstract\]) OR Fibrillation, Paroxysmal Atrial\[Title/Abstract\]) OR Atrial Fibrillations, Paroxysmal\[Title/Abstract\] Sort by: Relevance

\#6: \#4 OR \#5

\#7: Search "Blood Transfusion"\[Mesh\] OR "Blood Component Transfusion"\[Mesh\] OR "Blood Transfusion, Autologous"\[Mesh\] OR "Blood Transfusion, Intrauterine"\[Mesh\] OR "Platelet Transfusion"\[Mesh\] Sort by: Relevance

\#8: Search ((Transfusion, Blood\[Title/Abstract\]) OR Transfusions, Blood\[Title/Abstract\]) OR Blood Transfusions\[Title/Abstract\] Sort by: Relevance

\#9: \#7 OR \#8

\#10: Search "Erythrocyte Transfusion"\[Mesh\] Sort by: Relevance

\#11: Search ((((((Erythrocyte Transfusions\[Title/Abstract\]) OR Transfusion, Erythrocyte\[Title/Abstract\]) OR Transfusions, Erythrocyte\[Title/Abstract\]) OR Red Blood Cell Transfusion\[Title/Abstract\]) OR Transfusions, Red Blood Cell\[Title/Abstract\]) OR Transfusion, Red Blood Cell\[Title/Abstract\]) OR Red Blood Cell Transfusions\[Title/Abstract\] Sort by: Relevance

\#12: \#10 OR \#11

\#13: \#12 OR \#9

\#14: \#13 AND \#3 AND \#6
